372 related articles for article (PubMed ID: 11733272)
1. Clinical spectrum of primary ophthalmic rhabdomyosarcoma.
Shields CL; Shields JA; Honavar SG; Demirci H
Ophthalmology; 2001 Dec; 108(12):2284-92. PubMed ID: 11733272
[TBL] [Abstract][Full Text] [Related]
2. Primary ophthalmic rhabdomyosarcoma in 33 patients.
Shields CL; Shields JA; Honavar SG; Demirci H
Trans Am Ophthalmol Soc; 2001; 99():133-42; discussion 142-3. PubMed ID: 11797301
[TBL] [Abstract][Full Text] [Related]
3. Clinical Management of Orbital Rhabdomyosarcoma in a Referral Center in Spain.
Bravo-Ljubetic L; Peralta-Calvo J; Larrañaga-Fragoso P; Pascual NO; Pastora-Salvador N; Gomez JA
J Pediatr Ophthalmol Strabismus; 2016; 53(2):119-26. PubMed ID: 27018885
[TBL] [Abstract][Full Text] [Related]
4. Visual outcomes and late complications in paediatric orbital rhabdomyosarcoma.
Eade E; Tumuluri K; Do H; Rowe N; Smith J
Clin Exp Ophthalmol; 2017 Mar; 45(2):168-173. PubMed ID: 27473389
[TBL] [Abstract][Full Text] [Related]
5. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
[TBL] [Abstract][Full Text] [Related]
6. Ocular adnexal follicular lymphoma: a multicenter international study.
Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
[TBL] [Abstract][Full Text] [Related]
7. Survival after malignant tumors of the orbit and periorbit treated by exenteration.
Mouriaux F; Martinot V; Pellerin P; Patenotre P; Rouland JF; Constantinides G
Acta Ophthalmol Scand; 1999 Jun; 77(3):326-30. PubMed ID: 10406155
[TBL] [Abstract][Full Text] [Related]
8. Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.
Gandhi PD; Fleming JC; Haik BG; Wilson MW
Ophthalmic Plast Reconstr Surg; 2011; 27(4):241-6. PubMed ID: 21242849
[TBL] [Abstract][Full Text] [Related]
9. Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis.
Schoot RA; Saeed P; Freling NJ; Blank LE; Pieters BR; van der Grient JN; Strackee SD; Bras J; Caron HN; Merks JH;
Ophthalmic Plast Reconstr Surg; 2016; 32(5):354-60. PubMed ID: 26398242
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of orbital rhabdomyosarcoma in children in Japan.
Takahashi N; Minoda K
Jpn J Ophthalmol; 1991; 35(3):292-9. PubMed ID: 1770669
[TBL] [Abstract][Full Text] [Related]
11. Uveal Melanoma Metastasis to the Contralateral Eye Structures: A Retrospective Comparative Analysis of 13 Consecutive Patients.
Masoomian B; Mashayekhi A; Shields JA; Shields CL
Ophthalmol Retina; 2021 Oct; 5(10):1036-1042. PubMed ID: 33421627
[TBL] [Abstract][Full Text] [Related]
12. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor.
Graue GF; Finger PT; Maher E; Della Rocca D; Della Rocca R; Lelli GJ; Milman T
Eur J Ophthalmol; 2013; 23(3):344-55. PubMed ID: 23397158
[TBL] [Abstract][Full Text] [Related]
13. Localized orbital rhabdomyosarcoma. An interim report of the Intergroup Rhabdomyosarcoma Study Committee.
Wharam M; Beltangady M; Hays D; Heyn R; Ragab A; Soule E; Tefft M; Maurer H
Ophthalmology; 1987 Mar; 94(3):251-4. PubMed ID: 3587902
[TBL] [Abstract][Full Text] [Related]
14. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
15. Long-term evaluation of orbital rhabdomyosarcoma in children.
Boutroux H; Levy C; Mosseri V; Desjardins L; Plancher C; Helfre S; Freneaux P; Cellier C; Orbach D
Clin Exp Ophthalmol; 2015; 43(1):12-9. PubMed ID: 24923774
[TBL] [Abstract][Full Text] [Related]
16. Nodulo-Ulcerative Ocular Surface Squamous Neoplasia in 6 Patients: A Rare Presentation.
Kaliki S; Freitag SK; Chodosh J
Cornea; 2017 Mar; 36(3):322-326. PubMed ID: 27749454
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
[TBL] [Abstract][Full Text] [Related]
18. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B
Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
[TBL] [Abstract][Full Text] [Related]
19. Lymphoproliferative disease of the ocular adnexa: a clinical and pathologic study with statistical analysis of 69 patients.
Sullivan TJ; Whitehead K; Williamson R; Grimes D; Schlect D; Brown I; Dickie G
Ophthalmic Plast Reconstr Surg; 2005 May; 21(3):177-88. PubMed ID: 15942490
[TBL] [Abstract][Full Text] [Related]
20. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
